Triamterene and Hydrochlorothiazide
- Product NDC
- 70934-159
- 11-digit product format
- 709340159
- Labeler code
- 70934
- Product ID
- 70934-159_b9d09ca8-5edd-4820-e053-2a95a90a8754
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Triamterene and Hydrochlorothiazide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. DBA Northwind Pharmaceuticals
- Application
- ANDA073449
- Marketing category
- ANDA
- Marketing start
- 2018-08-28
- Marketing end
- 0000-00-00
- Substance
- TRIAMTERENE; HYDROCHLOROTHIAZIDE
- Active strength
- 38 mg/1; mg/1
- Pharmacologic classes
- Decreased Renal K+ Excretion [PE],Increased Diuresis [PE],Potassium-sparing Diuretic [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 70934-159-30 | Triamterene and Hydrochlorothiazide | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70934-159 | TRIAMTERENE AND HYDROCHLOROTHIAZIDE TABLET [DENTON PHARMA, INC. DBA NORTHWIND PHARMACEUTICALS] | 3 | Legacy NDC, 1 package rows | 20210128_75d80f11-5c51-df34-e053-2991aa0a67c2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-159-30 | 70934015930 | 30 TABLET in 1 BOTTLE, PLASTIC (70934-159-30) | 30 tablet | 2018-08-28 | 0000-00-00 | No | No | Current |